Next 10 |
home / stock / therf / therf news
CORAL GABLES, FL / ACCESSWIRE / October 29,2018 / Frost & Sullivan will be hosting a Growth Innovation Leadership (GIL) briefing titled "2019 Healthcare Predictions Unleashed - Growth Opportunities, Technology, and Trends." The firm already states that Globally, 2019 will be a year of ...
Noteworthy events for the week of October 28 - November 3 for healthcare investors. More news on: TherapeuticsMD, Newron Pharmaceuticals SPA, Enanta Pharmaceuticals, Inc., Healthcare stocks news, , Read more ...
Theratechnologies Inc. (THERF) Q3 2018 Results Earnings Conference Call October 4, 2018 08:30 AM ET Executives Denis Boucher - Vice President, Communications and Corporate Affaires Luc Tanguay - President and Chief Executive Officer Philippe Dubuc - Senior Vice President and Chi...
Theratechnologies ( OTCPK:THERF ): Q3 GAAP EPS of C$0.00. More news on: Theratechnologies Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Gilead Sciences (NASDAQ: GILD ) announces that newly created subsidiary Asegua Therapeutics LLC will launch authorized generic versions of hepatitis C meds Epclusa (sofosbuvir/velpatasvir) and Harvoni (ledipasvir/sofosbuvir) in the U.S. More news on: Gilead Sciences, Inc., AbbVie Inc., P...
Results from an exploratory Phase 3 trial of Alnylam Pharmaceuticals’s ( ALNY ) Phase 3 APOLLO study evaluating ONPATTRO (patisiran) for the treatment of polyneuropathy in hereditary transthyretin-mediated (hATTR) amyloidosis were just published in the journal Circulation . Left...
The European Medicines Agency (EMA) has accepted under accelerated review Theratechnologies' ( OTCPK:THERF ) marketing application seeking approval for Trogarzo (ibalizumab) for the treatment of multidrug-resistant HIV-1 infection in adults. More news on: Theratechnologies Inc., Healthca...
Theratechnologies ( OTCPK:THERF ) initiated with Sector Perform rating with a C$11 (flat) price target at RBC. More news on: Theratechnologies Inc., Tocagen Inc, Vaccinex, Healthcare stocks news, Stocks on the move, , Read more ...
Theratechnologies ( OTCPK:THERF -0.2% ) announces that it has filed a marketing application in Europe seeking approval for Trogarzo (ibalizumab-uiyk) for the treatment of adults with HIV-1 infection. More news on: Theratechnologies Inc., Healthcare stocks news, Read more ...
Stocks in the News: PBYI, KALA Puma Bio's Nerlynx marketing application in Canada under review Puma Biotechnology's ( PBYI ) New Drug Submission (‘NDS) for NERLYNX ( neratinib ) for the extended adjuvant treatment of adult patients with early-stage HER2-positive breast cancer is...
News, Short Squeeze, Breakout and More Instantly...
Theratechnologie Inc Company Name:
THERF Stock Symbol:
OTCMKTS Market:
CORAL GABLES, FL / ACCESSWIRE / October 29,2018 / Frost & Sullivan will be hosting a Growth Innovation Leadership (GIL) briefing titled "2019 Healthcare Predictions Unleashed - Growth Opportunities, Technology, and Trends." The firm already states that Globally, 2019 will be a year of ...
NEW YORK, NY / ACCESSWIRE / July 5, 2018 / Theratechnologies Inc. (OTC PINK: THERF ) will be discussing their earnings results in their Q2 Earnings Call to be held on July 5, 2018 at 8:30 AM Eastern Time. To listen to the event live or access a replay of the call - visit https://www.inve...
Toronto, Ontario--(Newsfile Corp. - March 6, 2018) - The following issues have been halted by IIROC: IIROC can make a decision to impose a temporary suspension of trading in a security of a publicly listed company, usually in anticipation of a material news announcement by the company. Tradin...